Article
Mitochondrial-targeted plastoquinone therapy ameliorates early onset muscle weakness that…
medRxiv · 2024 · Delfinis, L. J.; Khajehzadehshoushtar, S.; Flewwelling, L. J.; Andrews, N. J.; Garibotti, M. C.; Gandhi, S.; Brahmbhatt, A. N.; Morris, B. A.; Garlisi, B.; Lauks, S.; Aitken, C.; Tsitkanou, S.; Simpson, J. A.; Greene, N. P.; Cheng, A. J.; Petrik, J.; Perry, C. G. R.
Key facts
| Title | Mitochondrial-targeted plastoquinone therapy ameliorates early onset muscle weakness that precedes ovarian cancer cachexia in mice |
|---|---|
| First author | Delfinis, L. J.; Khajehzadehshoushtar, S.; Flewwelling, L. J.; Andrews, N. J.; Garibotti, M. C.; Gandhi, S.; Brahmbhatt, A. N.; Morris, B. A.; Garlisi, B.; Lauks, S.; Aitken, C.; Tsitkanou, S.; Simpson, J. A.; Greene, N. P.; Cheng, A. J.; Petrik, J.; Perry, C. G. R. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.10.22.619751 |
| Devices mentioned | DEN000008, K022086, K103302, K973350, K990827 |
| Product codes mentioned | JCI, KIP, KIT, NDS, NJT, OOI, JLX, KQP |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1